Recombinant production of human antimicrobial peptide LL- 37 and its secondary structure
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Recombinant production of human antimicrobial peptide LL- 37 and its secondary structure ; day:3 ; month:10 ; year:2023 ; pages:1-11
Biologia ; (3.10.2023), 1-11
- Klassifikation
-
Biowissenschaften, Biologie
- Urheber
-
Pavelka, Antonín
Vacek, Lukáš
Norek, Adam
Kobzová, Šárka
Janda, Lubomír
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11756-023-01539-8
- URN
-
urn:nbn:de:101:1-2023122421040794270662
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pavelka, Antonín
- Vacek, Lukáš
- Norek, Adam
- Kobzová, Šárka
- Janda, Lubomír
- SpringerLink (Online service)
Ähnliche Objekte (12)
The antimicrobial activity and mechanism of action of recombinant Ib-AMP4, an antimicrobial peptide from Impatiens balsamina
The antimicrobial activity and mechanism of action of recombinant Ib-AMP4, an antimicrobial peptide from Impatiens balsamina
Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37
Expression of a novel NaD1 recombinant antimicrobial peptide enhances antifungal and insecticidal activities
The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients
The impact of N-glycosylation on the properties of the antimicrobial peptide LL-III
Utilization of a recombinant defensin from Maize (Zea mays L.) as a potential antimicrobial peptide
Remodeling of the Fibrillation Pathway of α‐Synuclein by Interaction with Antimicrobial Peptide LL‐III
Remodeling of the fibrillation pathway of α-synuclein by interaction with antimicrobial peptide LL-III
LL-37_Renalexin hybrid peptide exhibits antimicrobial activity at lower MICs than its counterpart single peptides
The antimicrobial effect of a novel peptide LL-1 on Escherichia coli by increasing membrane permeability
The antimicrobial activity and mechanism of action of recombinant Ib-AMP4, an antimicrobial peptide from Impatiens balsamina
The antimicrobial activity and mechanism of action of recombinant Ib-AMP4, an antimicrobial peptide from Impatiens balsamina
Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37
Expression of a novel NaD1 recombinant antimicrobial peptide enhances antifungal and insecticidal activities
The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients
The impact of N-glycosylation on the properties of the antimicrobial peptide LL-III
Utilization of a recombinant defensin from Maize (Zea mays L.) as a potential antimicrobial peptide
Remodeling of the Fibrillation Pathway of α‐Synuclein by Interaction with Antimicrobial Peptide LL‐III
Remodeling of the fibrillation pathway of α-synuclein by interaction with antimicrobial peptide LL-III
LL-37_Renalexin hybrid peptide exhibits antimicrobial activity at lower MICs than its counterpart single peptides
The antimicrobial effect of a novel peptide LL-1 on Escherichia coli by increasing membrane permeability
The antimicrobial activity and mechanism of action of recombinant Ib-AMP4, an antimicrobial peptide from Impatiens balsamina
The antimicrobial activity and mechanism of action of recombinant Ib-AMP4, an antimicrobial peptide from Impatiens balsamina
Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37
Expression of a novel NaD1 recombinant antimicrobial peptide enhances antifungal and insecticidal activities
The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients
The impact of N-glycosylation on the properties of the antimicrobial peptide LL-III
Utilization of a recombinant defensin from Maize (Zea mays L.) as a potential antimicrobial peptide
Remodeling of the Fibrillation Pathway of α‐Synuclein by Interaction with Antimicrobial Peptide LL‐III
Remodeling of the fibrillation pathway of α-synuclein by interaction with antimicrobial peptide LL-III
LL-37_Renalexin hybrid peptide exhibits antimicrobial activity at lower MICs than its counterpart single peptides